An analysis of survival in patients with castrate-resistant prostate cancer receiving enzalutamide with treatment breaks:

Michael Rowe,Stuart Walter,Ayesha Hidayat,Adam Pollard,Timothy Norris,Deborah Victor,John McGrane,Alastair Thomson

An analysis of survival in patients with castrate-resistant prostate cancer receiving enzalutamide with treatment breaks:

2021

Michael Rowe
Stuart Walter
Ayesha Hidayat
Adam Pollard
Timothy Norris
Deborah Victor
John McGrane
Alastair Thomson

Objective:Enzalutamide is effective in treating metastatic castrate-resistant prostate cancer (mCRPC) but can have side effects that require treatment breaks (TB). We conducted a retrospective anal...

Keywords:

Medicine
Prostate cancer
Oncology
Enzalutamide
Castrate-resistant prostate cancer
Internal medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations